Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research9/3/2026Positive
MD
Mednax IncNYSEHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$2.20B
P/E Ratio
12.93
EPS
$2.09
Beta
0.65
52W High
$27.94
52W Low
$15.70
50-Day MA
$26.28
200-Day MA
$22.98
Dividend Yield
—
Profit Margin
8.96%
Forward P/E
8.21
PEG Ratio
0.24
About Mednax Inc
MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.
Fundamentals
| Revenue (TTM) | $1.95B |
| Gross Profit (TTM) | $511.77M |
| EBITDA | $263.74M |
| Operating Margin | 13.40% |
| Return on Equity | 20.40% |
| Return on Assets | 7.11% |
| Revenue/Share (TTM) | $23.87 |
| Book Value | $11.11 |
| Price-to-Book | 2.48 |
| Price-to-Sales (TTM) | 1.13 |
| EV/Revenue | 1.23 |
| EV/EBITDA | 8.47 |
| Quarterly Earnings Growth (YoY) | 6.50% |
| Quarterly Revenue Growth (YoY) | 4.00% |
| Shares Outstanding | $81.25M |
| Float | $77.92M |
| % Insiders | 2.01% |
| % Institutions | 107.89% |
Historical Volatility
HV 10-Day
14.99%
HV 20-Day
20.15%
HV 30-Day
30.99%
HV 60-Day
36.00%
HV Rank
27.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($26.33 target)
2
Buy5
HoldLatest News
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research9/1/2026Positive
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research8/20/2026Positive
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.
Zacks Investment Research8/13/2026Positive
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research8/12/2026Positive
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.
Zacks Investment Research8/6/2026Positive
Pediatrix Medical Group Q2 Earnings Call Highlights
Pediatrix Medical Group NYSE: MD reported second-quarter 2026 adjusted EBITDA of $76 million and reaffirmed its full-year adjusted EBITDA outlook of $280 million to $300 million, as stronger revenue-cycle-management collections, payer mix and patient acuity offset lower patient-service volumes.
MarketBeat8/5/2026Positive
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
Seeking Alpha8/4/2026Neutral
Pediatrix Medical Group (MD) Beats Q2 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.53 per share a year ago.
Zacks Investment Research8/4/2026Positive
Pediatrix Medical Group Reports Second Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Results.
Business Wire8/4/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MD and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026